Virginia Sanzone - Mar 6, 2022 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: VP, General Counsel
Signature: By: Paula Darbyshire, Attorney-in-fact For: Virginia Sanzone
Stock symbol: ICUI
Transactions as of: Mar 6, 2022
Transactions value $: -$388,445
Form type: 4
Date filed: 3/8/2022, 06:19 PM
Previous filing: Sep 13, 2021
Next filing: May 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	+1.44K	+89.97%	$0.00	3.05K	Mar 6, 2022	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$185K	-760	-24.93%	$242.93	2.29K	Mar 6, 2022	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+1.6K	+69.68%	$0.00	3.88K	Mar 6, 2022	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$204K	-839	-21.6%	$242.93	3.05K	Mar 6, 2022	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+2.27K	+74.61%	$0.00	5.32K	Mar 8, 2022	Direct	F1
transaction	ICUI	Common Stock	Tax liability	$0	-1.2K	-22.49%	$0.00	4.12K	Mar 8, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Common Stock	Award	$0	+3.22K		$0.00	3.22K	Mar 7, 2022	Common Stock	3.22K	$0.00	Direct	F2, F3, F4, F5
transaction	ICUI	Performance Shares	Options Exercise	$0	-2.27K	-33.33%	$0.00	4.55K	Mar 8, 2022	Common Stock	2.27K	$0.00	Direct	F1, F6, F7
transaction	ICUI	Performance Shares	Options Exercise	$0	-1.44K	-100%	$0.00^*	0	Mar 6, 2022	Common Stock	1.44K		Direct	F1, F6, F8
transaction	ICUI	Performance Shares	Options Exercise	$0	-1.6K	-50%	$0.00	1.6K	Mar 6, 2022	Common Stock	1.6K		Direct	F1, F6, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These Securities are Performance-based Restricted Stock Units (PRSU).
F2	These securities are Restricted Stock Units.
F3	There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5	These are restricted stock units that fully vest 3 years from the grant date.
F6	There is neither a purchase price nor an exercise price for the PRSUs.
F7	These PRSUs were granted on March 6, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F8	These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F9	These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.